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Abstract 
Background: Clinical studies have shown that pulsatile pressure is an independent risk factor 
for atherosclerosis.  However, it is unknown whether enhanced pulsatile pressure per se 
directly accelerates vascular smooth muscle cell (VSMC) migration, an important process of 
atherosclerosis.   
Methods and Results: Using our original pressure loading system with a Boyden chamber, I 
examined the direct effects of variable pressures and pulse rates on migration of rat aortic 
VSMCs in vitro.  In addition to high mean pressure (180/90 mmHg vs. 90/0 mmHg, with 
the same pulse pressure), wide pulse pressure (190/110 mmHg vs. 170/130 mmHg, with the 
same mean pressure) and high pulse rate (120/min vs. 40/min) significantly accelerated the 
VSMC migration (2.38, 1.38 and 1.27-fold, respectively).  The increase in intracellular 
calcium levels measured by fura-2/AM fluorescence was proportional to the magnitude of 
pressure loaded.  The pressure-promoted VSMC migration was abolished by an intracellular 
calcium chelator (BAPTA/AM), and was significantly inhibited by a phospholopase C 
inhibitor (U-73122) and a calmodulin inhibitor (W-7).  Inositol 1,4,5-trisphosphate (IP3) 
receptor blockers (2-aminoethoxydiphenyl borate and xestospongin C) significantly inhibited 
the VSMC migration, whereas a ryanodine receptor blocker (ryanodine) had no effects.  
Furthermore, a calcium channel blocker (CCB), azelnidipine, and an angiotensin type-1 
receptor blocker (ARB), olmesartan, also significantly inhibited the VSMC migration.  
Conclusions: These results provide the direct evidence for the atherogenic effects of 
enhanced pulsatile pressure and also suggest that the anti-atherogenic actions of CCBs and 
ARBs are mediated in part by their direct inhibitory effects on VSMC migration, independent 
of their blood pressure-lowering effects.      
 
Keywords: pulsatile pressure, vascular smooth muscle cell, migration, calcium. 
Tada T, et al. Page 3 
Introduction 
 
Hypertension is one of the most important risk factors for the initiation and development of 
atherosclerosis.1  Several clinical trials have shown that among the several hemodynamic 
factors, pulsatile pressure (mean pressure, pulse pressure, and pulse rate) is an independent 
risk factor for cardiovascular diseases.2-4  Indeed, the Framingham Heart Study has 
demonstrated that hypertension-related morbidity and mortality corresponded best with 
pulsatile pressure.5  The major determinant of pressure-induced remodeling in vivo may be a 
magnitude and/or mode of pulsatile pressure rather than a simple elevation of mean arterial 
pressure.6,7  Although the involvement of pulsatile pressure in the pathogenesis of 
atherosclerosis has been suggested by the above clinical studies,5,6 the detailed mechanisms 
for the atherogenic effects of pulsatile pressure remain to be examined. 
Proliferation and migration of vascular smooth muscle cells (VSMCs) are critical 
processes for the development of atherosclerosis.  Those VSMCs responses are regulated by 
several factors, among which mechanical stress may play a major role.8  Indeed, Hishikawa 
et al. have previously demonstrated that increased static pressure promotes VSMC 
proliferation.9  Onoue et.al. also have recently demonstrated that enhanced static pressure 
accelerates VSMC migration.10  However, it remains to be elucidated whether enhanced 
pulsatile pressure per se accelerates VSMC migration, and if so, what intracellular 
mechanisms are involved.   
In the present study, I thus directly addressed this important issue, using our original in 
vitro system with a Boyden chamber system that enables us to selectively examine the effects 
of variable types and magnitudes of pulsatile pressure on VSMC migration in the absence of 
the effects of shear stress or stretch.   
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Methods 
 
The present study was approved by the ethical committee on basic experiments of Tohoku 
University Graduate School of Medicine.   
 
Isolation and Culture of VSMCs 
A primary culture of VSMCs was performed as previously described.11  Thoracic and 
abdominal aortas were excised from Wistar rats weighing 200g under pentobarbital 
anesthesia (50 mg/kg IP) and rinsed in Hanks medium 199 (M199).  Loose connective tissue 
was removed with forceps, and the aortas were incubated without agitation for 30 minutes at 
37°C in the dispersing medium: 1 mg/mL collagenase, 0.1 mg/mL elastase, 0.5 mg/mL 
trypsin inhibitor, 1 mg/mL bovine serum albumin (BSA) in M199.  After the tunica 
adventitia was removed with the aid of forceps, the remaining tubes of tunica media and 
intima were placed in the fresh dispersing medium for 35 minutes at 37°C, and rinsed in 
M199.  Then the tubes of tunica media were minced with scissors, and incubated for 30 
minutes to isolate cells in the fresh dispersing medium.  The supernatant was stocked, and 
the deposition was reincubated in the fresh dispersing medium for 30 minutes.  This 
procedure was repeated 3 times.  The isolated cells were washed twice and resuspended in 
M199 containing 10% fetal bovine serum (FBS).  Using this method, culture of more than 
99% VSMC purity was routinely obtained.  The cells were cultured in Dulbecco’s modified 
Eagle’s medium (DMEM) containing 10% FBS in a humidified atmosphere of 5% CO2 and 
95% air at 37°C, and VSMCs of 5th to 10th passage were used.  The cells were identified as 
VSMCs by immunocytochemistry with a monoclonal anti-VSMC α-actin antibody.12  
 
Pressure-Loading Apparatus  
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To selectively examine the effects of pulsatile pressure on VSMC migration in vitro, I 
developed an original pressure-loading apparatus equipped with an intra-aortic balloon pump 
and a Boyden chamber (Figure 1).  Briefly, a custom-designed glass bottle was used as a 
pressure-loading apparatus, in which the membrane of a Boyden chamber was filled with 
VSMCs and a sufficient amount of saline was added in the bottom for humidification.  The 
glass bottle was then packed with a silicon plug that was connected to an intra-aortic balloon 
pump (IABP, System 90T, Datascope, Tokyo, Japan) with a manometer.  The insufflation 
from IABP changed the pressure of this closing circuit.  As a control, the same type of 
closing circuit with the same amount of air was prepared.  The loading pressure was 
monitored by a connected manometer, and was displayed on the IABP panel.  Variable types 
and magnitudes of pulsatile pressure were created by the IABP machine.  To confirm the 
absence of mechanical damage on VSMCs, the cell viability was assessed by trypan blue 
staining after loading the pressure. 
 
Boyden Chamber Assay 
Migration assay across the membrane was performed with modified Boyden chambers as 
previously described.13  Briefly, the membrane of the upper chamber with pores of 8 µm in 
diameter (BD Falcon, San Jose, CA) was pre-coated with fibronectin (1 µg/cm2).  The upper 
chamber containing VSMCs in M199 with 5% FBS was set on the lower chamber that was 
also filled with M199 containing 5% FBS.  Then, the chamber was exposed to variable 
types of pulsatile pressure by the above IABP system for 6 hours at 37°C.  After the cells on 
the upper surface of the membrane were removed with a cotton swab, the cells on the 
underside of the membrane were stained with Giemsa and counted by light microscopy at a 
magnification of ×40 (Figure 2).  VSMC migration activity was calculated as the mean 
number of migrated cells observed in 4 high-power fields and was obtained as a mean value 
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of 4 measurements. 
To investigate the effect of several inhibitors, the solution with an inhibitor or vehicle 
was administered to the medium at 1.5 hours after inserting the cells into the Boyden 
chamber.  
 
Measurement of Intracellular Calcium Levels 
Intracellular calcium levels were measured by the fura-2/AM method,14 using the optical 
systems for fluorescence signal detection.15,16  VSMCs, cultured semi-confluently on a flask, 
were loaded with 2 µmol/L fura-2/AM.  After loading pressure, the cells were excited on the 
stage of an inverted microscope (Nikon, Tokyo, Japan) at wavelengths of 340 and 380 nm 
with a Xenon lamp, and emission was recorded at 505 nm.  After background 
autofluorescence from unloaded VSMCs was subtracted at the end of each experiment, the 
ratio of emitted fluorescence (F340/F380) was calculated.  The fluorescence intensity was 
measured at a rate of 20 points/sec.    
 
Materials 
Collagenase, elastase, trypsin inhibitor, BSA, DMEM, M199, 2-aminoethyl diphenylborinate 
(2-APB), ryanodine from Ryania speciosa, U-73122, and monoclonal anti-VSMC α-actin 
antibody were obtained from Sigma Chemical Co. (St. Louis, MO).  FBS was obtained from 
Gibco Laboratories (Grand Island, NY).  O,O'-bis (2-aminophenyl) ethyleneglycol- 
N,N,N',N'-tetraacetic acid, tetraacetoxymethyl ester (BAPTA/AM) and fura-2/AM were 
obtained from Dojindo Laboratories (Kumamoto, Japan).  Xestospongin C and Giemsa were 
obtained from Merck (San Diego, CA). N-(6-aminohexyl)- 5-chloro-1- 
naphthalenesulfonamide hydrochloride (W-7) and N-(6-aminohexyl)-1- 
naphthalenesulfonamide hydrochloride (W-5) were obtained from Seikagaku Kogyo Co. 
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(Tokyo, Japan).  Fibronectin was obtained from Cosmo Bio Co. (Tokyo, Japan).  
Azelnidipine and olmesartan (RNH-6270) were kindly provided by Sankyo Pharmaceutical 
Co. (Tokyo, Japan). 
 
Statistical analysis 
All experiments were performed in triplicate.  The results were expressed as means ± SEM, 
and were analyzed by unpaired t-test with SPSS 11.0J (Chicago, IL).  A value of P<0.05 was 
considered to be statistically significant.   
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Results 
Cell viability 
To examine the presence of mechanical damage on VSMCs, the cell viability was assessed by 
trypan blue staining after loading the pressure.  Figure 3 shows that 6 hours after loading 
static or pulse pressure, the cell number was not different significantly.   
 
Effects of Static and Pulsatile Pressure on VSMC Migration  
The number of migrating VSMCs was significantly increased after 6 hours of pressurization 
more at higher static pressure (180 mmHg) than at lower static pressure (90 mmHg), a 
consistent finding with our recent report (Figure 4A).10  Under the same magnitude of pulse 
pressure, the VSMC migration was significantly increased more at higher pressure (180/90 
mmHg) than at lower pressure (90/0 mmHg) (Figure 4B).  Furthermore, even with the same 
mean pressure, the migration was increased more at a greater pulse pressure (190/110 mmHg) 
than at a smaller pulse pressure (170/130 mmHg) (Figure 4C).  Finally, with the same mean 
and pulse pressure, VSMC migration was increased more at a higher frequency (120/min) 
than at a lower frequency (40/min) (Figure 4D).   
 
Role of Intracellular Calcium in the Pressure-Promoted VSMC Migration  
The VSMC migration was completely inhibited by an intracellular calcium chelator, 
BAPTA/AM (50 µmol/L), under both pressure-free and pressure-loaded (180/90 mmHg, 
60/min) conditions (Figure 5A).  U-73122 (10 µmol/L), a phospholipase-C (PLC) blocker, 
also inhibited the migration under both conditions (Figure 5B).  W-7 (5 µmol/L), a 
calmodulin blocker, also inhibited the migration under pressure-loaded condition (180/90 
mmHg), but not under pressure-free condition, whereas its negative control, W-5 (5 µmol/L), 
had no effects (Figure 5C). 
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Effects of Inhibitors of IP3 Receptor and Ryanodine Receptor 
Intracellular calcium level, evaluated by F340/380 ratio with fura-2/AM fluorescence, was 
significantly increased in response to both static and pulse pressure (Figures 6).  Both IP3 
receptor and ryanodine receptor mediate calcium release from intracellular store site.17  IP3 
receptor blockers, 2-APB (100 µmol/L) and xestospongin C (10 µmol/L), did not affect 
intracellular calcium level under pressure-free condition, but abolished the increase in 
intracellular calcium level at 180/90 mmHg (Figures 7A and 7B).  By contrast, ryanodine 
(10 µmol/L), a ryanodine receptor blocker, had no effects under both pressure-free and 
pressure-loaded conditions (Figure 7C).  The inhibitory effects of 2-APB (100 µmol/L) and 
xestospongin C (10 µmol/L) on the VSMC migration were consistent with their inhibitory 
effects on intracellular calcium levels (Figures 7D and 7E).  Ryanodine (10 µmol/L) also 
had no effects on VSMC migration as was the case with intracellular calcium levels (Figure 
7F).    
 
Effects of a Calcium Channel Blocker and an Angiotensin Receptor Blocker 
Azelnidipine (1 µmol/L), an L-type calcium channel blocker (CCB), did not affect VSMC 
migration or intracellular calcium levels under pressure-free condition, but significantly 
inhibited pressure-promoted VSMC migration and the increase in intracellular calcium level 
at 180/90 mmHg (Figure 8).  Olmesartan (10 nmol/L), an angiotensin II type receptor 
blocker, did not affect VSMC migration or intracellular calcium levels under pressure-free 
condition, but significantly inhibited pressure-promoted VSMC migration without altering 
intracellular calcium levels at 180/90 mmHg (Figure 9).   
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Discussion 
 
The major findings of this study are that pulsatile pressure (mean pressure, pulse pressure, 
and pulse rate) is an important mechanical factor that promotes migration of rat aortic 
VSMCs in vitro, for which intracellular calcium release via IP3 receptors may be involved 
and that the anti-atherogenic effects of CCBs and ARBs may be mediated, at least in part, by 
their direct inhibitory effects on pressure-promoted VSMC migration, independent of their 
blood pressure-lowering effects (Figure 10).  
 
Role of VSMC Migration in the Pathogenesis of Atherosclerosis 
VSMC migration from the media to the intima is a critical process in the pathogenesis of 
atherosclerosis.18  VSMC migration is regulated by several cytokines, such as 
platelet-derived growth factor (PDGF) and angiotensin II.8  However, it remains to be 
examined whether mechanical stresses, in particular loading pressure, promote VSMC 
migration.  In the present study, I was able to provide the first evidence for this notion. 
In the present study, high mean pressure, wide pulse pressure, and high pulse rate all 
significantly accelerated migration of rat aortic VSMCs in vitro.  This is consistent with the 
clinical observations that hypertension accelerates atherosclerosis, where not only high mean 
pressure but also high pulse pressure and heart rate are associated with high mortality and 
morbidity in patients with hypertension.2-7  In the present study, I also showed that high 
pulse rate accelerates VSMC migration, suggesting that heart rate also influences the 
development of atherosclerosis, a consistent finding with the previous clinical studies.19  
The present results also indicate that VSMCs are able to sense not only the magnitude of but 
also the different kinds of pressure.  Taken together, these results suggest that 
pressure-related mechanical stresses could directly affect VSMC migration.  
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Intracellular Mechanisms of Pressure-Promoted VAMC Migration 
In the present study, both static and pulse pressure increased intracellular calcium level and 
the suppression of intracellular calcium by chelating with BAPTA/AM abolished the 
pressure-promoted VSMC migration.  The pressure-promoted VSMC migration was also 
inhibited by a PLC inhibitor (U-73122) and a calmodulin blocker (W-7).  PLC is known to 
be activated by several receptors such as G-protein coupled receptor.20-22  Activated PLC 
then up-regulates IP3, which binds to IP3 receptor of sarcoplasmic reticulum to promote the 
influx of calcium from the intracellular calcium store.22,23  Increased intracellular calcium 
then binds to calmodulin that plays an important role in cell migration.24,25  These results 
indicate that intracellular calcium signaling is one of the critical pathways for 
pressure-promoted VSMC migration (Figure 10).   
   Intracellular calcium release from sarcoplasmic reticulum is primarily mediated 
by IP3 and ryanodine receptors.17,23  It was reported that vortex-mediated mechanical stress 
induces THP-1 cell adhesion by IP3-mediated calcium release.26  The present study 
demonstrates that the pressure-promoted increase in intracellular calcium level is achieved 
through IP3-mediated calcium release from the intracellular calcium store.  This 
intracellular calcium release then acts as a potent stimulus for calcium influx from 
extracellular space through the opening of plasma membrane calcium channels, such as 
store-operated calcium channels (Figure 10).27  The present results suggest that 
pressure-promoted, IP3-sensitive calcium release from sarcoplasmic reticulum plays an 
important role in the pathogenesis of atherosclerosis in hypertension. 
The possible intracellular signaling pathways by which pressure promotes VSMC 
migration are shown in Figure 10.  It is widely known that calcium is a cationic second 
messenger critical for many cellular processes including VSMC migration.28  The receptors 
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activated by various agonists effectively transduce the extracellular signal into an intracellular 
calcium relay through activation of several intracellular proteins, including G-proteins, the 
phospholipase family and PI3-kinase (Figure 10).29  Several humoral factors, such as PDGF 
and angiotensin II, also regulate cell migration through intracellular calcium signaling 
pathway.30-33  PDGF accelerates cell migration through activation of PLC via PLC-β, the 
increase in intracellular calcium release from sarcoplasmic reticulum, and 
calcium-calmodulin pathway.34  The present results suggest that pressure-promoted signal 
transductions for VSMC migration resemble those induced by angiotensin II and PDGF. 
 
Effects of CCBs and ARBs 
In the present study, both azelnidipine and olmesartan effectively inhibited the 
pressure-promoted VSMC migration.  However, the mechanisms for their inhibitory effects 
may be different because azelnidipine suppressed both pressure-promoted VSMC migration 
and increase in intracellular calcium levels, whereas olmesartan only inhibited the former 
response.   
L-type calcium channels mediate calcium influx from extracellular space, when 
triggered by the calcium release from sarcoplasmic reticulum.35  The inhibition of 
pressure-promoted VSMC migration by azelnidipine may thus result from the suppression of 
calcium influx at the level of L-type calcium channels (Figure 10).  
On the other hand, the effect of ARB on the cell migration is not simply explained.  
Mentioned above, the mechanism of accelerated migration by pulse pressure resembled those 
induced by AT-II and PDGF.  Zou et al. reported that angiotensin II type I receptor (AT1R) 
would be one of the mechanosensers.36  However, the present study demonstrated that 
olmesartan suppressed the pressure-promoted VSMC migration without altering the increase 
in intracellular calcium levels.   
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AT1R is known to be coupled to various downstream signaling pathways in addition 
to calcium signaling.37  For example, Rho-kinase which is also activated by AT1R is closely 
involved in cell migration 38.  The previous study demonstrated that static pressure enhances 
Rho-kinase activity in VSMCs.10  The block of AT1R cause the inhibition of several 
downstream signal pathways.  In this study, olmesartan might suppress cell migration in 
total by inhibiting these pathways, although intracellular calcium was not significantly 
different.   
    
Limitations of the Study 
Several limitations should be mentioned for the present study.  First, it is 
conceivable that the agents used in the present study affect not only VSMC migration but also 
their adhesion.39  However, in the present study, since I confirmed that approximately 70% 
of VSMCs adhered to the membrane within 1.5 hours, I added each agent to the Boyden 
chamber after 1.5 hours in order to avoid the effects of the agent on VSMC adhesion.  
Second, it is possible that several humoral factors are released simultaneously in response to 
mechanical stress.40  This point remains to be examined in future studies.     
 
Clinical Implications 
The present study demonstrates that enhanced pulsatile pressures, including high 
mean pressure, wide pulse pressure, and high pulse rate, promote VSMC migration through 
intracellular calcium handling processes.  The present results also suggest that the 
anti-atherogenic actions of CCBs and ARBs are mediated, at least in part, by their inhibitory 
effects on VSMC migration, independent of their blood pressure lowering effects.  Thus, 
pulsatile pressure is an important therapeutic target in the treatment of hypertensive 
cardiovascular diseases.   
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Figure Legends 
 
Figure 1.  Schema of the original apparatus with a Boyden chamber  
This apparatus enables us to generate variables types and magnitudes of pulsatile pressure 
that were loaded on VSMCs to directly evaluate their migration responses in vitro.   
 
Figure 2.  VSMC stained with Giemsa on the underside of the membrane  
Light microscopy at a magnification of ×40.   
 
Figure 3.  Number of VSMC 6 hours after loading pressure 
Results are expressed as means ± SEM (n=7 each). 
 
Figure 4.  Effect of static and pulsatile pressure on VSMC migration   
High static pressure (A), high mean pressure (B), wide pulsatile pressure (C), and high 
frequency (D) accelerated VSMC migration of rat aortic VSMCs.  Each graph shows 
relative increase in the number of migrated cells under various pulsatile pressures as 
compared with that under atmospheric pressure.  Results are expressed as means ± SEM 
(n=7 each). 
 
Figure 5.  Effect of inhibitors of intracellular calcium levels on VSMC migration   
VSMC were preincubated with 50 µmol/L BAPTA/AM (a calcium chalator) or 10 µmol/L 
U-73122 (a PLC inhibitor) for 1h, 10 µmol/L W-7 (a selective calmodulin inhibitor) or W-5 
(its negative control) for 2 hours.  Both BAPTA/AM (A) and U-73122 (B) significantly 
inhibited the VSMC migration of rat aortic VSMCs under both no-pressure and pulsatile 
pressure condition (180/90 mmHg,? 60/min).  W-7 (C) also significantly inhibited the 
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VSMC migration under pulsatile pressure, but not under no-pressure condition.  Results are 
expressed as means ± SEM (n=7 each). 
 
Figure 6.  Measurement of intracellular calcium level 
Representative tracing of calcium fluorescence in response to pulsatile pressure (A) shows 
after pretreated with fura-2/AM fluorescence, rat aortic VSMCs were pressurized at 
90/0mmHg or 180/90mmHg.  F340/F380 ratio was increased in a stepwise manner in 
response to the pulsatile pressure.  Quantitative analysis of intracellular calcium in response 
to pressure shows static pressure (B) and pulsatile pressure (C) significantly increased 
intracellular calcium levels as evaluated by the ratio of F340/F380.  Results are expressed as 
means ± SEM (n=7 each). 
 
Figure 7.  Effects of IP3 blockers and ryanodine blocker on VSMC migration   
VSMC were preincubated with 100 µmol/L 2-APB, 10 µmol/L xestospongin C (a IP3 
receptor blocker), 10 µmol/L ryanodine (ryanodine channel blocker) for 1 hour. 
2-APB (A, D) and xestospongin C (B, E), significantly inhibited the pressure-promoted 
increase in intracellular calcium levels and VSMC migration, whereas ryanodine (C, F) had 
no effect.  Each graph shows a relative increase in F340/F380 ratio or VSMC migration 
under pulsatile pressure as compared with atmospheric pressure.  Results are expressed as 
means ± SEM (n=7 each). 
 
Figure 8.  Effect of a calcium channel blocker e on pressure-promoted VSMC 
migration and calcium increase.   
Azelnidipine (1 µmol/L), a calcium channel blocker, suppressed both VSMC migration (A) 
and increase in intracellular calcium levels (B) in response to pulsatile pressure.  Each graph 
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shows a relative increase in VSMC migration or F340/F380 ratio under pulsatile pressure as 
compared with atmospheric pressure.  Results are expressed as means ± SEM (n=7 each). 
 
Figure 9.  Effect of an angiotensin II receptor blocker on pressure-promoted VSMC 
migration   
Olmesartan, an angiotensin II receptor blocker (10 nmol/L) suppressed the pressure-promoted 
VSMC migration (A) but did not affect intracellular calcium levels (B).  Each graph shows a 
relative increase in VSMC migration or F340/F380 ratio under pulsatile pressure as compared 
with atmospheric pressure.  Results are expressed as means ± SEM (n=7 each). 
 
Figure 10.  Summary of the present findings. 
Stimulatory effects are shown by arrows and the inhibitory effects of several blockers are 
shown by line-heads.   
ATII, angiotensin II;  CaM, calmodulin;  GPCR, G-protein coupled receptor;  IP3R, 
inositol 1,4,5-trisphosphate (IP3) receptor;  MLCK, myosin light chain kinase;  PLC, 
phospholipase C;  RyR, ryanodine receptor;  SOCC, store-operated Ca Channel;  SR, 
sarcoplasmic reticulum.   
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